For the Inventor, By the Inventor

Enter inventor name

Linton, United Kingdom

David Winter Walker

USPTO Granted Patents = 17 (Patent Applications = 7)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 10 (Patent Applications = 13)

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 47(Granted Patents)

Location History:

Cambridge, GB (2013 - 2020)
Linton, GB (2012 - 2024)

Company Filing History:

Sentinel Oncology Limited

Astex Therapeutics Limited

The Institute of Cancer Research: Royal Cancer Hospital

4. 6 out of 262

Cancer Research Technology Limited

Cascadian Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...

Loading Chart...

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11884656 - Pyrrole derivatives as PLK1 inhibitors (2024-01-30),

2. 11786524 - Pharmaceutical compounds (2023-10-17),

3. 11208405 - Pyrrole derivatives as PLK1 inhibitors (2021-12-28),

4. 10973817 - Pharmaceutical compounds (2021-04-13),

5. 10730882 - 2-aminoquinazoline derivatives as P70S6 kinase inhibitors (2020-08-04),

6. 10344033 - 2-aminoquinazoline derivatives as P70S6 kinase inhibitors (2019-07-09),

7. 10144726 - Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancer (2018-12-04),

8. 10010547 - Pharmaceutical compounds (2018-07-03),

9. 9283226 - Pyrazole derivatives as protein kinase modulators (2016-03-15),

10. 9006430 - Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein (2015-04-14),

11. 8809336 - Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors (2014-08-19),

12. 8716473 - Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase (2014-05-06),

13. 8716287 - Pharmaceutical compounds (2014-05-06),

14. 8691806 - Pyrazole derivatives as protein kinase modulators (2014-04-08),

15. 8546407 - Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors (2013-10-01),

Title: The Innovative Journey of Inventor David Winter Walker

Introduction:

Meet David Winter Walker, a prolific inventor based in Linton, Great Britain, who has left a lasting impact on the field of pharmaceuticals with his groundbreaking patents.

Latest Patents:

David Winter Walker's latest patents showcase his expertise in developing compounds with significant medical applications. One notable invention is the "Pyrrole derivatives as PLK1 inhibitors," which are compounds crucial in treating various types of cancers. Additionally, his invention of "Pharmaceutical compounds" highlights the development of substances that modulate the activity of Chk-1 kinase, offering potential therapeutic benefits.

Career Highlights:

With an impressive total of 17 patents to his name, David Winter Walker has demonstrated a deep understanding of pharmaceutical innovation. He has actively contributed his expertise to renowned companies such as Sentinel Oncology Limited and Astex Therapeutics Limited, where his inventions have paved the way for novel treatments and medical advancements.

Collaborations:

Throughout his career, David Winter Walker has had the privilege of collaborating with esteemed professionals in the industry. Notable coworkers include Robert George Boyle and Valerio Berdini, whose collective efforts have bolstered the success of various projects and inventions.

Conclusion:

In conclusion, David Winter Walker's journey as an inventor embodies a steadfast commitment to innovation and scientific excellence. His remarkable contributions to the field of pharmaceuticals continue to inspire advancements in medicine and healthcare, leaving a lasting legacy in the realm of patent innovations.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…